CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,939,991 shares, a growth of 239,997.9% from the November 30th total of 808 shares. Based on an average daily volume of 30,134,177 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 30,134,177 shares, the days-to-cover ratio is presently 0.1 days.
CNBX Pharmaceuticals Stock Performance
Shares of OTCMKTS CNBX opened at $0.00 on Friday. CNBX Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $0.02.
About CNBX Pharmaceuticals
CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.
Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.
Read More
- Five stocks we like better than CNBX Pharmaceuticals
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
